BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Market Cap	157.04B
Revenue (ttm)	17.34B
Net Income (ttm)	6.21B
Shares Out	8.70M
EPS (ttm)	728.32
PE Ratio	24.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,514
Average Volume	41,541
Open	19,000
Previous Close	18,720
Day's Range	18,250 - 19,000
52-Week Range	12,230 - 23,100
Beta	0.77
RSI	40.99
Earnings Date	n/a

About BIO-FD&C

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, herbal extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, skin moisturizing, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 251120

Financial Performance

In 2024, BIO-FD&C's revenue was 16.07 billion, an increase of 3.04% compared to the previous year's 15.59 billion. Earnings were 4.50 billion, a decrease of -19.41%.